Flow Health Laboratories LLC

Flow Health Laboratories LLC was paid $1.68M by Medicaid between Nov 2020 and Jun 2022, across 3 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 72% of everything it billed.

33Billing provider infoFLOW HEALTH LABORATORIES LLC
CULVER CITY, CA 90232

33aNPI1144769068assigned 02/13/2017

33bProvider typeClinical Medical Laboratory

28Total paid$1.68M

24GClaims42,536

24DCodes billed3

24AFirst – last monthNov 2020 – Jun 2022

Compared with peers

Next to other Clinical Medical Laboratory providers in California

Rank by total paid#155 of 561

Median peer was paid$222K

This provider vs. median7.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	342	$8K
2021	4,203	$89K
2022	37,991	$1.58M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	72%	18,254	12,363	$1.20M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	15%	12,349	8,331	$250K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	14%	11,933	8,483	$227K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMESHKIN, ALEXANDER (MANAGER)

Same official

Other billing entities under MESHKIN, ALEXANDER

Full network →

Provider	Location	Paid
Signal Diagnostics LLC	Los Angeles, CA	$40.77M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.